Recently, Zhang et al, described that the combination of CA19.9, CO2, CRP and IL-6 distinguish pancreatic cancer from benign pancreatitis with 74.2% sensitivity at 90% specificity [16]. This evidence concerns the gene IL6 and familial pancreatic carcinoma.